Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants.
about
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAGene therapy for cancer treatment: past, present and futureSafety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)The environment and antiphospholipid syndrome.Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene
P2860
Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Elevated activated partial thr ...... ation of lupus anticoagulants.
@ast
Elevated activated partial thr ...... ation of lupus anticoagulants.
@en
type
label
Elevated activated partial thr ...... ation of lupus anticoagulants.
@ast
Elevated activated partial thr ...... ation of lupus anticoagulants.
@en
prefLabel
Elevated activated partial thr ...... ation of lupus anticoagulants.
@ast
Elevated activated partial thr ...... ation of lupus anticoagulants.
@en
P2093
P921
P1433
P1476
Elevated activated partial thr ...... ation of lupus anticoagulants.
@en
P2093
Bahaa S Malaeb
Gail Macik
Jay Y Gillenwater
Kenneth S Koeneman
Leland W K Chung
Thomas A Gardner
Vitaly Margulis
P304
P356
10.1016/J.UROLOGY.2005.04.041
P407
P577
2005-10-01T00:00:00Z